Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

TATYANA MARY JACQUI JOAB

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1730615295
CMS profile
11394665
Location
CLEVELAND, TN

General Payments · PY2022–2024

$2,851.92

  • Reported across 94 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$866.05

39 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $810.69 33
Education $55.36 6

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $487.47 14
PY2023 $1,498.40 41
PY2024 $866.05 39

Payment records · PY2024 (39)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $15.66 02/06/2024 Food and Beverage Undisputed 01/23/2026 1115767330 CMS
Amgen Inc. $6.15 03/15/2024 Food and Beverage Undisputed 01/23/2026 1117589351 CMS
Amgen Inc. $12.49 03/21/2024 Food and Beverage Undisputed 01/23/2026 1117589355 CMS
Amgen Inc. $22.25 03/27/2024 Food and Beverage Undisputed 01/23/2026 1117589353 CMS
Amgen Inc. $13.31 05/28/2024 Food and Beverage Undisputed 01/23/2026 1117589357 CMS
Amgen Inc. $19.09 05/29/2024 Food and Beverage Undisputed 01/23/2026 1115767337 CMS
Amgen Inc. $6.22 06/27/2024 Food and Beverage Undisputed 01/23/2026 1117589359 CMS
Amgen Inc. $123.95 08/22/2024 Food and Beverage Undisputed 01/23/2026 1117589361 CMS
Amgen Inc. $17.20 12/04/2024 Food and Beverage Undisputed 01/23/2026 1117589363 CMS
Ardelyx, Inc. $23.29 02/24/2024 Food and Beverage Undisputed 01/23/2026 1146687089 CMS
AstraZeneca Pharmaceuticals LP $21.50 04/19/2024 Food and Beverage Undisputed 01/23/2026 1105762762 CMS
AstraZeneca Pharmaceuticals LP $14.97 10/04/2024 Food and Beverage Undisputed 01/23/2026 1104426987 CMS
AstraZeneca Pharmaceuticals LP $13.55 11/01/2024 Food and Beverage Undisputed 01/23/2026 1104696726 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.65 02/05/2024 Food and Beverage Undisputed 01/23/2026 1118132537 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.66 06/04/2024 Food and Beverage Undisputed 01/23/2026 1118132539 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $13.90 10/03/2024 Food and Beverage Undisputed 01/23/2026 1118132535 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.80 12/03/2024 Food and Beverage Undisputed 01/23/2026 1118132541 CMS
CALLIDITAS THERAPEUTICS US INC. $97.53 02/22/2024 Food and Beverage Undisputed 01/23/2026 1141509893 CMS
CALLIDITAS THERAPEUTICS US INC. $16.39 12/09/2024 Food and Beverage Undisputed 01/23/2026 1141529039 CMS
Lilly USA, LLC $13.12 10/07/2024 Food and Beverage Undisputed 01/23/2026 1135455563 CMS
Lilly USA, LLC $15.36 11/12/2024 Food and Beverage Undisputed 01/23/2026 1135460932 CMS
Mallinckrodt Hospital Products Inc. $21.30 07/16/2024 Food and Beverage Undisputed 01/23/2026 1145087987 CMS
Novartis Pharmaceuticals Corporation $30.20 02/07/2024 Food and Beverage Undisputed 01/23/2026 1087120760 CMS
Novartis Pharmaceuticals Corporation $30.67 09/03/2024 Food and Beverage Undisputed 01/23/2026 1087120776 CMS
Novartis Pharmaceuticals Corporation $33.74 09/24/2024 Food and Beverage Undisputed 01/23/2026 1087120782 CMS
Novo Nordisk Inc $16.51 03/08/2024 Food and Beverage Undisputed 01/23/2026 1096991424 CMS
Novo Nordisk Inc $13.82 10/25/2024 Food and Beverage Undisputed 01/23/2026 1096826532 CMS
Novo Nordisk Inc $32.27 12/18/2024 Education Undisputed 01/23/2026 1096740763 CMS
NXSTAGE MEDICAL, INC. $72.24 05/22/2024 Food and Beverage Undisputed 01/23/2026 1154282751 CMS
OPKO Pharmaceuticals, LLC $13.74 01/31/2024 Food and Beverage Undisputed 01/23/2026 1112845752 CMS
OPKO Pharmaceuticals, LLC $17.16 07/10/2024 Food and Beverage Undisputed 01/23/2026 1112845754 CMS
OPKO Pharmaceuticals, LLC $14.17 12/11/2024 Food and Beverage Undisputed 01/23/2026 1112845756 CMS
Travere Therapeutics, Inc. $3.08 03/05/2024 Education Undisputed 01/23/2026 1149928402 CMS
Travere Therapeutics, Inc. $11.48 03/05/2024 Food and Beverage Undisputed 01/23/2026 1149928406 CMS
Travere Therapeutics, Inc. $16.89 03/05/2024 Education Undisputed 01/23/2026 1149928410 CMS
Travere Therapeutics, Inc. $0.37 08/05/2024 Education Undisputed 01/23/2026 1149928390 CMS
Travere Therapeutics, Inc. $0.37 10/07/2024 Education Undisputed 01/23/2026 1149928394 CMS
Travere Therapeutics, Inc. $2.38 12/17/2024 Education Undisputed 01/23/2026 1149928398 CMS
Travere Therapeutics, Inc. $23.62 12/17/2024 Food and Beverage Undisputed 01/23/2026 1149928413 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.